122 related articles for article (PubMed ID: 19252525)
21. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle.
Hu Q; Lu JF; Luo R; Sen S; Maity SN
Nucleic Acids Res; 2006; 34(21):6272-85. PubMed ID: 17098936
[TBL] [Abstract][Full Text] [Related]
23. Characterization of an E2F-p130 complex formed during growth arrest.
Corbeil HB; Branton PE
Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
[TBL] [Abstract][Full Text] [Related]
24. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
[TBL] [Abstract][Full Text] [Related]
25. Deletion of the p107/p130-binding domain of Mip130/LIN-9 bypasses the requirement for CDK4 activity for the dissociation of Mip130/LIN-9 from p107/p130-E2F4 complex.
Sandoval R; Pilkinton M; Colamonici OR
Exp Cell Res; 2009 Oct; 315(17):2914-20. PubMed ID: 19619530
[TBL] [Abstract][Full Text] [Related]
26. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
[TBL] [Abstract][Full Text] [Related]
27. Rb may act as a transcriptional co-activator in undifferentiated F9 cells.
Bocco JL; Reimund B; Chatton B; Kedinger C
Oncogene; 1993 Nov; 8(11):2977-86. PubMed ID: 8414500
[TBL] [Abstract][Full Text] [Related]
28. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
Calvisi DF; Simile MM; Ladu S; Frau M; Evert M; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo F; Pascale RM
Hepatology; 2011 Apr; 53(4):1226-36. PubMed ID: 21480327
[TBL] [Abstract][Full Text] [Related]
29. Mip/LIN-9 regulates the expression of B-Myb and the induction of cyclin A, cyclin B, and CDK1.
Pilkinton M; Sandoval R; Song J; Ness SA; Colamonici OR
J Biol Chem; 2007 Jan; 282(1):168-75. PubMed ID: 17098733
[TBL] [Abstract][Full Text] [Related]
30. c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression.
Nakata Y; Shetzline S; Sakashita C; Kalota A; Rallapalli R; Rudnick SI; Zhang Y; Emerson SG; Gewirtz AM
Mol Cell Biol; 2007 Mar; 27(6):2048-58. PubMed ID: 17242210
[TBL] [Abstract][Full Text] [Related]
31. Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb.
Down CF; Millour J; Lam EW; Watson RJ
Biochim Biophys Acta; 2012 Aug; 1819(8):855-62. PubMed ID: 22513242
[TBL] [Abstract][Full Text] [Related]
32. LIN54 is an essential core subunit of the DREAM/LINC complex that binds to the cdc2 promoter in a sequence-specific manner.
Schmit F; Cremer S; Gaubatz S
FEBS J; 2009 Oct; 276(19):5703-16. PubMed ID: 19725879
[TBL] [Abstract][Full Text] [Related]
33. Cell cycle regulation by the B-Myb transcription factor.
Joaquin M; Watson RJ
Cell Mol Life Sci; 2003 Nov; 60(11):2389-401. PubMed ID: 14625684
[TBL] [Abstract][Full Text] [Related]
34. Activation of human B-MYB by cyclins.
Sala A; Kundu M; Casella I; Engelhard A; Calabretta B; Grasso L; Paggi MG; Giordano A; Watson RJ; Khalili K; Peschle C
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):532-6. PubMed ID: 9012818
[TBL] [Abstract][Full Text] [Related]
35. The retinoblastoma family member p107 binds to B-MYB and suppresses its autoregulatory activity.
Sala A; De Luca A; Giordano A; Peschle C
J Biol Chem; 1996 Nov; 271(46):28738-40. PubMed ID: 8910512
[TBL] [Abstract][Full Text] [Related]
36. Mitotic cyclins stimulate the activity of c-Myb-like factors for transactivation of G2/M phase-specific genes in tobacco.
Araki S; Ito M; Soyano T; Nishihama R; Machida Y
J Biol Chem; 2004 Jul; 279(31):32979-88. PubMed ID: 15175336
[TBL] [Abstract][Full Text] [Related]
37. Cyclin B1 transcription is enhanced by the p300 coactivator and regulated during the cell cycle by a CHR-dependent repression mechanism.
Wasner M; Tschöp K; Spiesbach K; Haugwitz U; Johne C; Mössner J; Mantovani R; Engeland K
FEBS Lett; 2003 Feb; 536(1-3):66-70. PubMed ID: 12586340
[TBL] [Abstract][Full Text] [Related]
38. The transcription factor B-Myb is essential for S-phase progression and genomic stability in diploid and polyploid megakaryocytes.
García P; Frampton J
J Cell Sci; 2006 Apr; 119(Pt 8):1483-93. PubMed ID: 16551698
[TBL] [Abstract][Full Text] [Related]
39. B-Myb, a repressed trans-activating protein.
Ansieau S; Kowenz-Leutz E; Dechend R; Leutz A
J Mol Med (Berl); 1997; 75(11-12):815-9. PubMed ID: 9428611
[TBL] [Abstract][Full Text] [Related]
40. Myb controls G(2)/M progression by inducing cyclin B expression in the Drosophila eye imaginal disc.
Okada M; Akimaru H; Hou DX; Takahashi T; Ishii S
EMBO J; 2002 Feb; 21(4):675-84. PubMed ID: 11847115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
